MH3 COST-EFFECTIVENESS OF LONG-ACTING METHYLPHENIDATE FOR TREATMENT OF ATTENTIONDEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS IN FINLAND- AN EVALUATION BASED UPON A RANDOMIZED CLINICAL TRIAL (RCT)

Nov 1, 2008, 00:00 AM
10.1016/S1098-3015(10)66179-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)66179-7/fulltext
Section Title :
Section Order : 13
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66179-7&doi=10.1016/S1098-3015(10)66179-7
HEOR Topics :
Tags :
Regions :